These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3159026)

  • 21. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
    Gangjee A; Zhu Y; Queener SF
    J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of trimethoprim, paracetamol and cimetidine on trimetrexate metabolism by rat perfused isolated livers.
    Webster LK; Tong WP; McCormack JJ
    J Pharm Pharmacol; 1987 Nov; 39(11):942-4. PubMed ID: 2892922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of trimetrexate, a new non-classical antifolate, in infusion solutions.
    Stetson PL; Shukla UA; Ensminger WD
    J Chromatogr; 1989 Feb; 464(1):163-71. PubMed ID: 2523896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450.
    Rodrigues AD; Lewis DF; Ioannides C; Parke DV
    Xenobiotica; 1987 Nov; 17(11):1315-27. PubMed ID: 3433801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.
    Back DJ; Tjia JF
    Br J Pharmacol; 1985 May; 85(1):121-6. PubMed ID: 4027461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole.
    Niemegeers CJ; Levron JC; Awouters F; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):26-38. PubMed ID: 6266358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.
    Gangjee A; Zhu Y; Queener SF; Francom P; Broom AD
    J Med Chem; 1996 Apr; 39(9):1836-45. PubMed ID: 8627607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
    Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
    Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
    Hostetler KA; Wrighton SA; Molowa DT; Thomas PE; Levin W; Guzelian PS
    Mol Pharmacol; 1989 Mar; 35(3):279-85. PubMed ID: 2784534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimetrexate: clinical development of a nonclassical antifolate.
    O'Dwyer PJ; DeLap RJ; King SA; Grillo-Lopez AJ; Hoth DF; Leyland-Jones B
    NCI Monogr; 1987; (5):105-9. PubMed ID: 2963228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes.
    Schulz M; Schmoldt A
    Xenobiotica; 1988 Aug; 18(8):983-9. PubMed ID: 3142156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action.
    Rosenthal GJ; Weigand GW; Germolec DR; Blank JA; Luster MI
    J Immunol; 1988 Jul; 141(2):410-6. PubMed ID: 2968399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer.
    Reece PA; Morris RG; Bishop JF; Olver IN; Raghavan D
    Cancer Res; 1987 Jun; 47(11):2996-9. PubMed ID: 2952262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of rat microsomal epoxide hydrolase gene by imidazole antimycotic agents.
    Kim SG
    Mol Pharmacol; 1992 Aug; 42(2):273-9. PubMed ID: 1513325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of imidazole- and 2-methyl imidazole-containing farnesyl-protein transferase inhibitors: interaction with and metabolism by rat hepatic cytochrome P450s.
    Tang C; Chiba M; Nishime J; Hochman JH; Chen I; Williams TM; Lin JH
    Drug Metab Dispos; 2000 Jun; 28(6):680-6. PubMed ID: 10820141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.